期刊文献+

不同高压造影参数在前列腺动脉栓塞术中的参考价值

The Application Value of Different High Pressure Contrast Agent Parameters in Prostatic Artery Embolization
暂未订购
导出
摘要 目的:探讨3d DSA下使用不同高压造影参数构建前列腺动脉(prostatic arteries,PA)血管显影图像在前列腺动脉栓塞术(prostatic artery embolization,PAE)操作中的参考价值。方法:回顾性选取2022年10月1日至2023年12月1日于郑州大学第五附属医院介入科行PAE的良性前列腺增生(benign prostatic hyperplasia,BPH)80例患者。根据术中给予患者高压造影剂用量参数的不同,将其分为A、B两组,各40人。A组:注射造影剂量5 mL/s,总量30 mL,压力400 psi;B组:注射造影剂量4 mL/s,总量24 mL,压力400 psi。对比A、B两组患者术中的手术操作总时长、一侧插管时间、一侧插管X射线辐射剂量、造影时疼痛值(NRS)、高压造影总次数、住院天数、术后6个月随访前列腺体积、国际前列腺症状评分(International Prostate Symptom Score,IPSS)、生活质量评分(quality of life score,QOL)等指标,分析两组方案对患者术中及术后的参考价值。结果:两组患者均完成手术(100%),A、B组患者手术操作总时长[(81.83±3.87)min vs.(105.27±4.52)min]、一侧插管时间[(11.67±0.89)min vs.(18.03±1.59)min]、插管过程一侧插管X射线辐射剂量[(434.58±19.11)mGy vs.(685.04±31.58)mGy]A组均小于B组,组间差异具有统计学意义(P<0.05)。A、B两组造影时疼痛值(numerical rating scale,NRS)、造影次数、住院天数、术后6个月随访前列腺体积、IPSS、QOL各指标组间差异无统计学意义(P>0.05)。结论:A组采用造影剂设定参数相较于B组能更好地指导术者寻找前列腺动脉,减少术中插管时间、操作总时长及X射线辐射剂量,提高手术效率,对PAE操作有重要参考意义。 Objective:To investigate the value of constructing angiographic images of prostatic arteries(PA)using different high-pressure contrast agent parameters under 3 d DSA in prostatic artery embolization(PAE).Methods:Eighty patients with benign prostatic hyperplasia(BPH)who accepted PAE in the Department of Interventional of the Fifth Affiliated Hospital of Zhengzhou University from October 1st 2022 to December 1st 2023 were retrospectively selected.According to the different parameters of intra-operative high-pressure contrast dosage given to the patients,they were divided into two groups of 40 patients each.Group A:injected contrast dosage of 5 mL/s,total volume of 30 mL,and pressure of 400 psi;Group B:injected contrast dosage of 4 mL/s,total volume of 24 mL,and pressure of 400 psi.The total time of operation,the time of intubation in one side,the dose of X-ray radiation in one side durning intubation,the pain numerical rating scale during radiography(NRS),the times of radiography,the days of hospitalization,the prostate volume at 6 month postoperative follow up,the International Prostate Symptom Score(IPSS),and the quality of life score(QOL)were contrasted to analyze the value of the application of two groups of protocols to the patients in the intraoperative and postoperative periods.Results:Both groups of patients completed the operation(100%),and the total length of surgical operation[(81.83±3.87)min vs.(105.27±4.52)min],the time of one side intubation[(11.67±0.89)min vs.(18.03±1.59)min],and the ra-diation dose of X-rays from one-side intubation during the intubation process[(434.58±19.11)mGy vs.(685.04±31.58)mGy]were all smaller in group A than in group B,and the difference between the groups was statistically significant(P<0.05).There was no statistically significant difference between the groups of A and B(P>0.05)in the pain NRS during radiography,the days of hospitalization,the prostate volume at the 6 month postoperative follow up,IPSS and QOL for each index.Conclusion:Compared with group B,group A using contrast agent setting parameters can better guide the operator to find the prostatic artery,reduce the intraoperative intubation time,total operation time,and X radiation dose,as well as improve the efficiency of the operation,which is an important reference significance for the operation of PAE.
作者 朱舸 吕军 李晋 刘凯 ZHU Ge;LYU Jun;LI Jin;LIU Kai(Interventional Department,the Fifth Affiliated Hospital of Zhengzhou University,Henan 450052,China)
出处 《影像技术》 2025年第4期55-59,66,共6页 Image Technology
关键词 前列腺动脉栓塞术 良性前列腺增生 3d DSA 高压造影参数 prostatic artery embolization benign prostatic hyperplasia 3d DSA high pressure contrast agent parameters
  • 相关文献

参考文献15

二级参考文献84

  • 1于涯涛,李忠华.前列腺血管构筑及其临床意义[J].中国临床解剖学杂志,1993,11(4):262-264. 被引量:6
  • 2周荣祥,高文彬,侯成玉,孟凡学,迟玉友,燕东亮,尹洪山,孙兆忠,施利国.环扎血管前列腺切除术的解剖学研究及应用[J].中华泌尿外科杂志,1995,16(9):548-550. 被引量:70
  • 3陈秀清,欧良明.前裂腺动脉和神经丛的解剖观察及其临床意义[J].中华外科杂志,1989,27(6):373-375. 被引量:3
  • 4高元安,张瑞,冯宝安,曾妍.动脉栓塞治疗前列腺增生12例[J].中华放射学杂志,2006,40(12):1314-1316. 被引量:26
  • 5李吉.髂内动脉分支的研究[J].解剖学报,1964,7(2):458-467.
  • 6Mary MC,Michael JB.Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Am J Med,2005,118:1331-1339.
  • 7American Urological Association Practice Guidelines Committee.American Urological Association guideline on management of benign prostatic hyperplasia (2003).Chapter 1.Diagnosis and treatment recommendations.J Urol,2003,170:530-547.
  • 8Roehrborn CG,Boyle P,Nichol JC,et al.Efficacy and safety of a dual inhibitor of 5-alpha reductase types 1 and 2(dutasteride) in men with benign prostatic hyperplasia.Urology,2002,60:434-441.
  • 9Lepor H,Williford WO,Barry MJ,et al.The efficacy of terazosin,finasteride,or both in benign prostatic hyperplasia.Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.N Engl J Med,1996,335:533-539.
  • 10McConnell JD,Roehrbom CG,Bautista OM,et al.The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med,2003,349:2387-2398.

共引文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部